The Personalised Medicine Coalition (PMC) has praised Qatar’s continuous efforts to advance personalised medicine in its monthly landscape analysis. Building on this recognition, the report added that Qatar is making significant strides in its ambitious plan to integrate personalised medicine into its national healthcare strategy, aiming to reinforce economic development and improve the quality of life for its population.
In a recent briefing to PMC, Hamad Medical Corporation (HMC) officials emphasised personalised medicine’s critical role in the country’s National Vision 2030. The magazine emphasised the centre’s innovative approaches to optimal patient care, showcasing its cutting-edge research, state-of-the-art technology, and dedicated team of experts. The article underscores how Qatar has made personalised medicine a principal component of its plans to grow the economy and enhance the lives of its people.
PMC is a crucial organisation that advocates for promoting and advancing personalised medicine. It unites healthcare providers, researchers, patient groups, and industry leaders to drive innovation, influence policies, and educate the public, enhancing patient outcomes through tailored treatments.
Personalised medicine, or precision medicine, is a medical approach that tailors healthcare to individual patients based on their genetic makeup, lifestyle, and environment. Considering these unique factors, it aims to create more effective and precise treatment plans, improving outcomes and reducing adverse effects.
Director of the Center for Clinical Precision Medicine and Genomics, Chairperson of Medical Oncology and Palliative Care and a leading figure at HMC, Dr Salha Bujassoum al-Bader, said personalised medicine is a central component of the plan to sustain economic development and provide a high standard of living for the people of Qatar, affirming that by embracing this paradigm shift, Qatar is committed to accomplishing profound changes across all patient populations and disease states.
Within Qatar, there is a firm belief that the adoption of precision medicine initiatives will translate into enhanced health outcomes for all citizens.
The efforts are geared towards creating a healthcare system that is proactive, predictive, and precise, ensuring that every individual receives the right treatment at the right time, Dr al-Bader highlighted.
Since launching its National Vision 2030, Qatar has shown a solid commitment to personalised medicine. This dedication triumphed with the establishment of the Center for Clinical Precision Medicine and Genomics at HMC this year, Qatar’s leading provider of specialised healthcare services. This centre is set to become a cornerstone in Qatar’s healthcare infrastructure, driving forward the nation’s goals in personalised medicine.
Additionally, Qatar’s commitment to personalised medicine aims to elevate the standard of healthcare within the country and contribute significantly to global research clinical care, medical education and innovation.
The continued investment and development in this field reflect Qatar’s dedication to fostering a healthier future for its citizens and enhancing its international standing in medical excellence.
